In this issue:
AURA: avelumab-based neoadjuvant therapies in MIBC
BladderPath: mpMRI vs. TURBT for new bladder cancer staging
NEODURVARIB: molecular dynamics of neoadjuvant durvalumab + olaparib in resectable urothelial bladder cancer
Tumour location on TURBT predictive of ipsilateral pelvic lymph-nodal metastasis
IMMERSE: standard TURBT vs. immediate second resection in non-MIBC
Micropapillary component on TURBT & lymph-node metastasis at radical cystectomy
Long-term outcomes with robotassisted radical cystectomy
REBACARE: pre-operative mitomycin C instillation in upper urinary tract urothelial carcinoma
Economic burden of bladder cancer
Long-term QoL after radical cystectomy for bladder cancer
Please login below to download this issue (PDF)